ARTICLE | Company News
GlycoDesign autoimmune/inflammation news
April 21, 2003 7:00 AM UTC
GD restructured and reduced its headcount to 15 from 34. GD said the move will reduce costs prior to the completion of its previously announced acquisition by Inflazyme Pharmaceuticals Ltd. (TSE:IZP,...